Related Experiment Video
Updated: May 12, 2026

Treatment with Vancomycin Loaded Calcium Sulphate and Autogenous Bone in an Improved Rabbit Model of Bone Infection
Published on: March 14, 2019
[Intravenous antibiotic therapy for acute hematogenous osteomyelitis in children: short versus long course]
S Bouchoucha1, K Gafsi, M Trifa
1Service d'orthopédie de l'enfant et de l'adolescent, hôpital d'enfants de Tunis, 1007 Tunis Jabbari, Bab Saadoun, Tunisie. sami.bouchoucha@yahoo.com
Insights
Shortened intravenous antibiotic therapy for acute hematogenous osteomyelitis in children, lasting 7 days, proved as effective as a 14-day protocol. This finding supports optimized treatment durations for pediatric osteomyelitis.
Area of Science:
- Pediatric Infectious Diseases
- Orthopedic Surgery
- Pharmacology
Background:
- Osteomyelitis is a bone infection requiring prompt antibiotic treatment.
- The optimal duration of intravenous antibiotic therapy for acute hematogenous osteomyelitis in children is not definitively established.
- Prolonged antibiotic courses may increase risks and healthcare costs.
Purpose of the Study:
- To compare the efficacy of a 7-day intravenous antibiotic protocol versus a 14-day protocol for treating acute hematogenous osteomyelitis in children.
- To evaluate the rate of chronic osteomyelitis development following different treatment durations.
Main Methods:
- A prospective randomized study involving 53 children diagnosed with acute hematogenous osteomyelitis.
- Group 1 (G1) received 7 days of intravenous antibiotics.
- Group 2 (G2) received 14 days of intravenous antibiotics.
- Treatment effectiveness was assessed by the absence of chronic osteomyelitis signs at follow-up.
Main Results:
- A total of 53 patients were included (G1=27, G2=26).
- The mean follow-up period was 11.5 months.
- No patients in either group exhibited signs of chronic osteomyelitis.
- Both 7-day and 14-day intravenous antibiotic regimens demonstrated comparable efficacy.
Conclusions:
- A 7-day intravenous antibiotic treatment course is as effective as a 14-day course for pediatric acute hematogenous osteomyelitis.
- Shortened antibiotic durations may be a safe and effective option, potentially reducing treatment burden.
- Further research could explore even shorter durations or oral switch protocols.
Abstract:
The aim of this study was to evaluate the results of two antibiotic therapy protocols for osteomyelitis with different durations of intravenous treatment. This was a prospective randomized study of children treated for acute hematogenous osteomyelitis. Patients in group 1 (G1) received 7 days of intravenous antibiotics, whereas patients in group 2 (G2) received 14 days. Treatment was deemed effective if there were no signs of chronic osteomyelitis at the last follow-up. Fifty-three patients were included in the study (G1=27, G2=26). After a mean follow-up of 11.5 months, none of the patients in either group showed signs of chronic osteomyelitis. In conclusion, a shortened treatment of 7 days of intravenous antibiotic therapy is as effective as a longer treatment.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Dosage Interval and Administration Route: Determination Methods
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Pharmacokinetics in Pediatric Patients: Drug Excretion
Acute Pyelonephritis I: Introduction
